Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/BAMM stock hub

CSE/BAMM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/BAMMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

203

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/BAMM

In the news

Latest news · CSE/BAMM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-1,150.2

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/BAMM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

156

Groups with data

Currency

USD

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	142
Employees Change	14%
Employees Change Percent	10.94
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	US09689V1008
Last refreshed	2026-05-10
Market cap	CAD 203
Price	CAD 0.03
Price currency	CAD
Rev Per Employee	222,377.37x
Sector	Healthcare
Sic	2834
Symbol	cse/BAMM
Website	https://www.bodyandmind.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9,407,645.81%
FCF yield	-2,937,050.68%
P/B ratio	-0x
P/S ratio	0x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-30.9%
EBITDA Margin	-24.88%
Gross margin	7.96%
Gross Profit	CAD 2.5M
Gross Profit Growth	18.84%
Gross Profit Growth Q	-8.11%
Gross Profit Growth3 Y	-36.28%
Gross Profit Growth5 Y	5.94%
Net Income	CAD -19.1M
Net Income Growth Quarters	4%
Pretax Margin	-85.04%
Profit Margin	-60.45%
Profit Per Employee	CAD -134,436
ROA	-18.19
Roa5y	-8.06
ROCE	-116.8
Roe5y	-1,094.4
ROIC	-1,150.2
Roic5y	-23.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-72.15%
Cagr3y	-56.07%
Cagr5y	-45.06%
EPS Growth Quarters	3
Revenue Growth	75.17x
Revenue Growth Q	5.63x
Revenue Growth3 Y	4.75x
Revenue Growth5 Y	40.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.94
Assets	CAD 22.2M
Cash	CAD 400,697
Current Assets	CAD 6.4M
Current Liabilities	CAD 13.8M
Debt	CAD 16.8M
Debt FCF	CAD -2.83
Equity	CAD -16.4M
Interest Coverage	-2.67
Liabilities	CAD 38.6M
Long Term Assets	CAD 15.8M
Long Term Liabilities	CAD 24.8M
Net Cash	CAD -16.4M
Net Cash By Market Cap	CAD -8.1M
Tangible Book Value	CAD -22.9M
Tangible Book Value Per Share	CAD -0.16
WACC	17.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.46
Inventory Turnover	12.65
Net Working Capital	CAD -5.9M
Quick ratio	0.25
Working Capital	CAD -7.4M
Working Capital Turnover	CAD -7.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-72.22%
200-day SMA	0.07
3Y total return	-91.53%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-95%
All Time High	3.71
All Time High Change	-99.33%
All Time High Date	2019-04-24
All Time Low	0.01
All Time Low Change	150%
All Time Low Date	2016-07-05
ATR	0
Beta	45
Ch YTD	25
High	0.03
High52	0.12
High52 Date	2024-03-26
High52ch	-79.17%
Low	0.03
Low52	0.01
Low52 Date	2024-12-16
Low52ch	150%
Ma50ch	7.76%
Price vs 200-day SMA	-61.6%
RSI	56.51
RSI Monthly	36.7
RSI Weekly	41.33
Sharpe ratio	0.63x
Sortino ratio	1
Total Return	-16.33%
Tr YTD	25
Tr1m	66.67%
Tr3m	-28.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -9.8M
Operating margin	-30.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-9,063,704.2
Shares Qo Q	1.3%
Short Ratio	0

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -6.1M
Average Volume	62,032.75x
Bv Per Share	-0.12
CAPEX	CAD -191,946
Ch1m	66.67
Ch1y	-72.22
Ch3m	-28.57
Ch3y	-91.53
Ch5y	-95
Ch6m	-44.44
Change	0%
Close	0.03
Depreciation Amortization	1,891,625.4
Earnings Date	2025-11-14
EBIT	CAD -9.8M
EBITDA	CAD -7.9M
EPS	CAD -0.13
F Score	3
FCF	CAD -6M
Financing CF	-9,112,436
Fiscal Year End	July
Founded	1,998
Income Tax	CAD 3.7M
Investing CF	11,942,395
Is Primary Listing	0
Last Earnings Date	2025-11-14
Last Report Date	2024-04-30
Ma150	0.05
Ma150ch	-52.92%
Ma20	0.02
Ma20ch	26.26%
Net CF	-3,016,596
Open	0
Ppne	7,702,808.6
Price Date	2025-01-27
Relative Volume	2.29x
Revenue	31,577,586x
SBC By Revenue	0.48x
Share Based Comp	150,186
Tax By Revenue	11.86x
Tr6m	-44.44%
Volume	0
Z Score	-6.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/BAMM pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/BAMM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

CSE/BAMM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.5

Neutral momentum band

Price vs 200-day MA

-61.6%

50/200-day relationship not available

Beta (5Y)

45.00

More volatile than the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/BAMM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/BAMM stock rating?

cse/BAMM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/BAMM analysis?

The full report lives at /stocks/cse/BAMM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/BAMM?

The latest report frames cse/BAMM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/BAMM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.